» |
The FDA is currently analyzing Actos® clinical data to determine whether further regulatory action, such as an Actos® recall, is warranted. |
Actos®
 Oral diabetes medication Actos® (generic name pioglitazone) is made by Takeda Pharmaceutical Company and co-marketed in the United States by Eli Lilly Pharmaceuticals. Actos® and related drugs are used to control type-2 diabetes in patients whose condition is not adequately controlled by diet and exercise alone.
Actos® belongs to a class of drugs called Thiazolidinedione drugs, which help to treat Type-2 diabetes by lowering blood glucose levels and increasing the body’s sensitivity to insulin. This drug may be prescribed alone (as Actos®) or in combination with other active ingredients such as metformin (sold as Actoplus met) or glimepiride (sold as duetact). A patient’s drug regiment may also include insulin or other medications in addition to those containing pioglitazone.
Type-2 diabetes, which affects approximately 18 to 20 million Americans, is characterized by high blood glucose levels caused by the body’s inability to properly use insulin. This disease, left untreated, can lead to blindness, kidney problems, and cardiovascular disease.
The FDA
Amidst an intense debate over the safety of Type-2 diabetes drugs, the FDA has asked the makers of Actos® to issue a black box warning. A black box warning is the strongest FDA-requested label change that can be added to a drug.
The FDA is currently analyzing Actos® clinical data to determine whether further regulatory action, such as an Actos® recall, is warranted.
NEW: Long-term use of Actos® increases cancer risk
FDA recently issued a drug safety communication warning patients and health professionals that use of pioglitazone (Actos—Takeda) for more than 1 year may be associated with an increased risk of bladder cancer. A French study, conducted by the nation’s health insurance agency, examined cancer rates and found an increasing risk in bladder cancer.
Act Now
If you or loved one has been diagnosed with bladder cancer after taking Actos®, please call the Steinberg Law Firm P.C. at 888-529-4688 or email andrewsteinberg@lawyer.com for a free consultation.
Consult A Lawyer on Legal Issues
We encourage you to contact us at 888-529-4688
to discuss your Actos® case with an experienced personal
injury and wrongful death attorney.
| » Fill out this form if you need additional information or want to discuss a potential claim with an attorney. All inquiries are kept strictly confidential. Please e-mail Andrew E. Steinberg* at: andrewsteinberg@lawyer.com for a free, confidential consultation, or call us at 888-529-4688. |
| » If the inquiry is accepted for further review, you will receive a prompt response (usually the same day or by the next business day). |
Consult A Doctor On Medical Issue
The Steinberg law firm does not intend, by this web site
or otherwise, to dissuade anyone from taking medication
without their doctors' approval. Please consult your
doctor, not your lawyer, on matters relating to your
health. It could be dangerous to stop taking medicines,
especially abruptly. Patients should talk to their physicians
to decide whether the benefits and risks of taking Actos®
make it the right choice for them.
|
